Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and marketing of surgical solutions for peripheral nerve regeneration and repair. It provides products and educational resources to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
622
Employees622
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
622
Employees622

AXGN Key Statistics

Market cap
2.99B
Market cap2.99B
Price-Earnings ratio
-74.95
Price-Earnings ratio-74.95
Dividend yield
—
Dividend yield—
Average volume
2.52M
Average volume2.52M
High today
$50.29
High today$50.29
Low today
$48.14
Low today$48.14
Open price
$48.56
Open price$48.56
Volume
1.67M
Volume1.67M
52 Week high
$52.91
52 Week high$52.91
52 Week low
$23.00
52 Week low$23.00

Stock Snapshot

With a market cap of 2.99B, Axogen(AXGN) trades at $49.93. The stock has a price-to-earnings ratio of -74.95.

On 2026-11-06, Axogen(AXGN) stock traded between a low of $48.14 and a high of $50.29. Shares are currently priced at $49.93, which is +3.7% above the low and -0.7% below the high.

Axogen(AXGN) shares are trading with a volume of 1.67M, against a daily average of 2.52M.

In the last year, Axogen(AXGN) shares hit a 52-week high of $52.91 and a 52-week low of $23.00.

In the last year, Axogen(AXGN) shares hit a 52-week high of $52.91 and a 52-week low of $23.00.

AXGN News

Simply Wall St 5d
Is Axogen Undervalued As Strong Q3 Results Lifted Full Year Guidance?

Advertisement Why Axogen’s Latest Earnings Matter For Investors Axogen (AXGN) released third quarter results on 28 October 2026, reporting higher sales and ne...

Is Axogen Undervalued As Strong Q3 Results Lifted Full Year Guidance?
Simply Wall St 7d
Learn Why The Bull Case For Axogen Could Change Following Raised Revenue Guidance

Axogen reported third quarter 2026 sales of US$75.83 million and net income of US$2.33 million, and raised full year 2026 revenue guidance to at least US$290 mi...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.